Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126260591 | 12626059 | 1 | I | 20160721 | 20160805 | 20160805 | EXP | E2B_00506460 | CA-HQ SPECIALTY-CA-2016INT000700 | INTERCHEM | 0.00 | F | Y | 0.00000 | 20160805 | CN | CA | CA |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126260591 | 12626059 | 1 | PS | METHOTREXATE SODIUM. | METHOTREXATE SODIUM | 1 | UNK | U | 201749 | ||||||||||
126260591 | 12626059 | 2 | SS | ENBREL | ETANERCEPT | 1 | Subcutaneous | UNK | U | 0 | |||||||||
126260591 | 12626059 | 3 | SS | ACTEMRA | TOCILIZUMAB | 1 | UNK | U | 0 | ||||||||||
126260591 | 12626059 | 4 | SS | CIMZIA | CERTOLIZUMAB PEGOL | 1 | Subcutaneous | UNK | U | 0 | |||||||||
126260591 | 12626059 | 5 | SS | FOLIC ACID. | FOLIC ACID | 1 | UNK | U | 0 | ||||||||||
126260591 | 12626059 | 6 | SS | FOSAMAX | ALENDRONATE SODIUM | 1 | UNK | U | 0 | ||||||||||
126260591 | 12626059 | 7 | SS | HUMIRA | ADALIMUMAB | 1 | Subcutaneous | UNK | U | 0 | |||||||||
126260591 | 12626059 | 8 | SS | ORENCIA | ABATACEPT | 1 | Intravenous (not otherwise specified) | UNK | U | 0 | |||||||||
126260591 | 12626059 | 9 | SS | PHTHALYLSULFATHIAZOLE | PHTHALYLSULFATHIAZOLE | 1 | UNK | U | 0 | ||||||||||
126260591 | 12626059 | 10 | SS | PLAQUENIL /00072602/ | HYDROXYCHLOROQUINE DIPHOSPHATE | 1 | UNK | U | 0 | ||||||||||
126260591 | 12626059 | 11 | SS | PREDNISONE. | PREDNISONE | 1 | UNK | U | 0 | ||||||||||
126260591 | 12626059 | 12 | SS | REACTINE /00884302/ | CETIRIZINE HYDROCHLORIDE | 1 | UNK | U | 0 | ||||||||||
126260591 | 12626059 | 13 | SS | RITUXAN | RITUXIMAB | 1 | Intravenous (not otherwise specified) | UNK | U | 0 | |||||||||
126260591 | 12626059 | 14 | SS | SIMPONI | GOLIMUMAB | 1 | Subcutaneous | UNK | U | 0 | |||||||||
126260591 | 12626059 | 15 | SS | ARAVA | LEFLUNOMIDE | 1 | UNK | U | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126260591 | 12626059 | 1 | Product used for unknown indication |
126260591 | 12626059 | 2 | Product used for unknown indication |
126260591 | 12626059 | 3 | Product used for unknown indication |
126260591 | 12626059 | 4 | Product used for unknown indication |
126260591 | 12626059 | 5 | Product used for unknown indication |
126260591 | 12626059 | 6 | Product used for unknown indication |
126260591 | 12626059 | 7 | Product used for unknown indication |
126260591 | 12626059 | 8 | Product used for unknown indication |
126260591 | 12626059 | 9 | Product used for unknown indication |
126260591 | 12626059 | 10 | Product used for unknown indication |
126260591 | 12626059 | 11 | Product used for unknown indication |
126260591 | 12626059 | 12 | Product used for unknown indication |
126260591 | 12626059 | 13 | Product used for unknown indication |
126260591 | 12626059 | 14 | Rheumatoid arthritis |
126260591 | 12626059 | 15 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126260591 | 12626059 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126260591 | 12626059 | Abdominal discomfort | |
126260591 | 12626059 | Alopecia | |
126260591 | 12626059 | Glossodynia | |
126260591 | 12626059 | Hip arthroplasty | |
126260591 | 12626059 | Knee arthroplasty | |
126260591 | 12626059 | Maternal exposure during pregnancy | |
126260591 | 12626059 | Pain | |
126260591 | 12626059 | Pemphigus | |
126260591 | 12626059 | Rheumatoid arthritis | |
126260591 | 12626059 | Systemic lupus erythematosus |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |